The ASPirin in Reducing Events in the Elderly (ASPREE) study was a randomised controlled trial of aspirin in 19,114 people aged 70 years or older (65 or older for US minorities) conducted between March 2010 and June 2017 in Australia and the US. ASPREE collected detailed longitudinal clinical, cognitive, anthropometric, mood and function data on randomised participants. Alongside the main trial multiple sub-studies were conducted on subgroups of the ASPREE cohort. These sub-studies collected biospecimens and additional imaging, sleep, hearing, demographic and sociological data. Data collection continues in the ASPREE-eXTension (ASPREE-XT) cohort study, a longitudinal observational cohort study of ASPREE participants.
The ASPREE Access Management Site (AMS) is specifically designed to help researchers familiarise themselves with the complex ASPREE and sub-study data that is available, and to request access to that data.
We invite you to explore the data documentation to see what is available and to submit a request for data access or for implementation of a new sub-study (i.e. new data collection or biospecimen analysis).